273 related articles for article (PubMed ID: 22172453)
21. A novel purification method of murine embryonic stem cell- and human-induced pluripotent stem cell-derived cardiomyocytes by simple manual dissociation.
Shinozawa T; Furukawa H; Sato E; Takami K
J Biomol Screen; 2012 Jun; 17(5):683-91. PubMed ID: 22274911
[TBL] [Abstract][Full Text] [Related]
22. Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients.
Lepperhof V; Polchynski O; Kruttwig K; Brüggemann C; Neef K; Drey F; Zheng Y; Ackermann JP; Choi YH; Wunderlich TF; Hoehn M; Hescheler J; Sarić T
PLoS One; 2014; 9(9):e107363. PubMed ID: 25226590
[TBL] [Abstract][Full Text] [Related]
23. Generation of functional cardiomyocytes from mouse induced pluripotent stem cells.
So KH; Han YJ; Park HY; Kim JG; Sung DJ; Bae YM; Yang BC; Park SB; Chang SK; Kim EY; Park SP
Int J Cardiol; 2011 Dec; 153(3):277-85. PubMed ID: 20870305
[TBL] [Abstract][Full Text] [Related]
24. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.
Braam SR; Passier R; Mummery CL
Trends Pharmacol Sci; 2009 Oct; 30(10):536-45. PubMed ID: 19762090
[TBL] [Abstract][Full Text] [Related]
25. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart.
Kawamura M; Miyagawa S; Fukushima S; Saito A; Miki K; Ito E; Sougawa N; Kawamura T; Daimon T; Shimizu T; Okano T; Toda K; Sawa Y
Circulation; 2013 Sep; 128(11 Suppl 1):S87-94. PubMed ID: 24030425
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin-A potently induces highly cardiogenic progenitors from embryonic stem cells.
Yan P; Nagasawa A; Uosaki H; Sugimoto A; Yamamizu K; Teranishi M; Matsuda H; Matsuoka S; Ikeda T; Komeda M; Sakata R; Yamashita JK
Biochem Biophys Res Commun; 2009 Jan; 379(1):115-20. PubMed ID: 19094963
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
[TBL] [Abstract][Full Text] [Related]
28. Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction.
Ishida M; Miyagawa S; Saito A; Fukushima S; Harada A; Ito E; Ohashi F; Watabe T; Hatazawa J; Matsuura K; Sawa Y
Transplantation; 2019 Feb; 103(2):291-298. PubMed ID: 30119058
[TBL] [Abstract][Full Text] [Related]
29. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro.
Kuzmenkin A; Liang H; Xu G; Pfannkuche K; Eichhorn H; Fatima A; Luo H; Saric T; Wernig M; Jaenisch R; Hescheler J
FASEB J; 2009 Dec; 23(12):4168-80. PubMed ID: 19703934
[TBL] [Abstract][Full Text] [Related]
31. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models.
Dambrot C; Passier R; Atsma D; Mummery CL
Biochem J; 2011 Feb; 434(1):25-35. PubMed ID: 21269276
[TBL] [Abstract][Full Text] [Related]
32. Endogenous cardiac stem cells.
Barile L; Messina E; Giacomello A; Marbán E
Prog Cardiovasc Dis; 2007; 50(1):31-48. PubMed ID: 17631436
[TBL] [Abstract][Full Text] [Related]
33. Cardiomyocyte differentiation from embryonic and adult stem cells.
Passier R; Mummery C
Curr Opin Biotechnol; 2005 Oct; 16(5):498-502. PubMed ID: 16099156
[TBL] [Abstract][Full Text] [Related]
34. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
Hodonsky C; Wu K; Mundada L; Si MS
Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
[TBL] [Abstract][Full Text] [Related]
35. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
36. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
Duelen R; Sampaolesi M
EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
[TBL] [Abstract][Full Text] [Related]
37. Cardiac stem cell therapy for myocardial regeneration. A clinical perspective.
Dawn B; Zuba-Surma EK; Abdel-Latif A; Tiwari S; Bolli R
Minerva Cardioangiol; 2005 Dec; 53(6):549-64. PubMed ID: 16333238
[TBL] [Abstract][Full Text] [Related]
38. From pluripotency to distinct cardiomyocyte subtypes.
David R; Franz WM
Physiology (Bethesda); 2012 Jun; 27(3):119-29. PubMed ID: 22689787
[TBL] [Abstract][Full Text] [Related]
39. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
Yoshida Y; Yamanaka S
Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
[No Abstract] [Full Text] [Related]
40. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE
Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
